PHARMACOKINETIC ANALYSES OF LEDIPASVIR/SOFOSBUVIR IN HCV-INFECTED SUBJECTS WITH ADVANCED LIVER DISEASE AND/OR FOLLOWING LIVER TRANSPLANTATION

被引：0
|
作者：
Garrison, K. L. [1 ]
German, P. [1 ]
Arterburn, S. [1 ]
De-Oertel, S. [1 ]
Brainard, D. [1 ]
Ling, J. [1 ]
Jin, F. [1 ]
Mathias, A. [1 ]
机构：
[1] Gilead, Foster City, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)01538-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-198
引用
收藏
页码：S789 / S789
页数：1
相关论文
共 50 条
  • [11] Antiviral therapy in HCV-infected cirrhotic patients awaiting liver transplantation
    Carrion, Jose A.
    Navasa, Miquel
    Forns, Xavier
    JOURNAL OF HEPATOLOGY, 2009, 51 (05) : 960 - 962
  • [12] High Efficacy of Sofosbuvir/Ledipasvir Without Ribavirin in Patients With HCV Recurrence After Liver Transplantation
    Elfeki, Mohamed A.
    Abou Mrad, Rachel
    Esfeh, Jamak Modaresi
    Zein, Nizar N.
    Eghtesad, Bijan
    Hanouneh, Ibrahim A.
    Alkhouri, Naim
    GASTROENTEROLOGY, 2016, 150 (04) : S1098 - S1098
  • [13] EFFICACY AND SAFETY OF PEGUILATED INTERFERON AND RIBAVIRIN IN HCV-INFECTED PATIENTS WITH ADVANCED CIRRHOSIS AWAITING LIVER TRANSPLANTATION
    Feldner, A. C. C. A.
    Ribeiro, T. C. R.
    Bragagnolo, M. A., Jr.
    Seda-Neto, J.
    Brito, J. D. R.
    Trindade, L. Z.
    Oliveira, E. M. G.
    Parise, E. R.
    Kondo, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S107 - S107
  • [14] Medications Altering Sex Hormone Balance and Risk of Advanced Liver Disease in HCV-infected Males
    Hashmi, Ali
    Ramsey, David
    El-Serag, Hashem
    Tabasi, Shahriar
    Avila, Nathaniel
    White, Donna
    Kuzniarek, Jill
    Pascua, Rhia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S122 - S122
  • [15] Pharmacokinetics of Once Daily Sofosbuvir or Ledipasvir/Sofosbuvir in HCV-Infected Pediatrics Aged 3 to <6 Years Old
    Begley, Rebecca
    Meng, Amy
    Massetto, Benedetta
    Shao, Jiang
    Ling, John
    Mathias, Anita
    HEPATOLOGY, 2018, 68 : 582A - 582A
  • [16] Pharmacokinetics of Once Daily Sofosbuvir or Ledipasvir/Sofosbuvir in HCV-Infected Pediatrics Aged 6 to <12 Years Old
    Garrison, Kimberly L.
    Mathias, Anita
    Kersey, Kathryn
    Kanwar, Bittoo
    Ni, Liyun
    Jain, Anant
    Ling, John
    Gonzalez-Peralta, Regino P.
    Murray, Karen F.
    Lin, C-H
    Whitworth, Mary Suzanne
    Wen, Jessica
    Schwarz, Kathleen B.
    Balistreri, William
    HEPATOLOGY, 2016, 64 : 436A - 436A
  • [17] Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant Recipients
    Levitsky, Josh
    Verna, Elizabeth C.
    O'Leary, Jacqueline G.
    Bzowej, Natalie H.
    Moonka, Dilip K.
    Hyland, Robert H.
    Arterburn, Sarah
    Dvory-Sobol, Hadas
    Brainard, Diana M.
    McHutchison, John G.
    Terrault, Norah A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2106 - 2108
  • [18] HAART and the HCV-infected liver: friend or foe?
    Sulkowski, MS
    JOURNAL OF HEPATOLOGY, 2004, 41 (01) : 181 - 184
  • [19] miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation
    Bulfoni, Michela
    Pravisani, Riccardo
    Dalla, Emiliano
    Cesselli, Daniela
    Hidaka, Masaaki
    Di Loreto, Carla
    Eguchi, Susumu
    Baccarani, Umberto
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (08) : 4992 - 5000
  • [20] Ledipasvir and sofosbuvir for recurrent hepatitis C after liver transplantation
    Oya, Yuki
    Sugawara, Yasuhiko
    Watanabe, Takehisa
    Yoshimaru, Yoko
    Honda, Masaki
    Hashimoto, Shintaro
    Yoshii, Daiki
    Isono, Kaori
    Hayashida, Shintaro
    Yamamoto, Hidekazu
    Tanaka, Motohiko
    Sasaki, Yutaka
    Inomata, Yukihiro
    BIOSCIENCE TRENDS, 2016, 10 (06) : 496 - 499
12345